A Double Blind Placebo Control Study to Assess the Safety,Tolerability and Efficacy of Copaxone in Crohn's Disease

NCT00731172 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER_GOV

Sponsor class

Conditions

Crohns Disease

Interventions

DRUG: glatiramer acetate
DRUG: placebo

Sponsor

Tel-Aviv Sourasky Medical Center

Collaborators

[object Object]
[object Object]